EUVIMEDEUVIMED entdecken
Crossref

L26/P-346 Three-dimensional sonohysterography as a screening test for chronic endometritis: a patient-friendly, minimally invasive tool in infertility practice

R. Papa, M. Costa, A. Rodriguez-Fuentes, R. Vicario, G. Martín-Palumbo, J.P. Rouleau, D. Vasquez Carlon, L. Ciocci, J. Hernandez, A. Palumbo

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von R. Papa und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can three-dimensional sonohysterography (3D SHG) identify chronic endometritis (CE) through the detection of micropolypoid endometrium with a diagnostic accuracy comparable to diagnostic hysteroscopy? Summary answer 3D SHG shows 99% concordance with hysteroscopy for micropolypoid endometrium. What is known already As reported by Greenwood and Moran (Obstet. Gynecol 1981), morphological features of value in diagnosing CE are superficial stromal edema, increased stromal density and pleomorphic stromal inflammatory infiltrate dominated by lymphocytes, associated with the presence of plasmacells. Localization of plasmacells may be difficult, often leading to underdiagnosis when using the precence of these cells as the gold standard. The recent definition of hysteroscopic criteria for diagnosing CE, including micropolyps, stromal edema and hyperemia has shed new light in the clinical recognition of CE and has created the need for a critical revision of pathologic and diagnostic criteria of this condition. Study design, size, duration This ambispective cohort study included a total of 124 hysteroscopies performed between January 2023 and December 2025. Sixty-eight cases were analyzed retrospectively and 56 prospectively. All procedures were performed during the proliferative phase of the cycle. A total of 95 sonohysterographies were performed, some of which were followed by more than one hysteroscopy. All patients underwent directed endometrial biopsies. A single operator performed all procedures, and the same pathologist evaluated all samples. Participants/materials, setting, methods All patients showing micropolypoid endometriun at 3D SHG underwent hysteroscopy and the presence of micropolyps, hyperemia and stromal edema was described. In the prospective cohort the following grading was applied: micropolyps (0–2), hyperemia (0–3),edema (0-1). Inmunohystochemistry (IHC) for CD138 was performed in all cases. The correlation between grading and number of plasmacells was assessed by Spearman’s coefficient. Main results and the role of chance The positive predictive value (PPV) of 3D SHG for detecting mycropolyps at hysteroscopy was 99% (94/95 cases). Among patients with an hysteroscopic diagnosis of CE, the overall PPV for histological confirmation by CD138+ was 35% (43/124). When analyzed by cohort, the PPV was 30.8% in the retrospective group (21/68) and improved to 40% in the prospective group (22/55).. Overall, 35.7% (34/95) of patients with micropolypoid endometrium initially detected via SHG were histologically confirmed as CE by IHC. There was a trend towards a positive correlation between the severity of hysteroscopic grading and number of plasmacells but it did not reach statistical significance (micropolypoid endometrium vs. CD138+: r_spearman = 0.41); Hyperemia vs. CD138+: r_spearman = 0.44). Limitations, reasons for caution The negative predictive value was not analyzed in this study, however previous studies have demonstrated the accuracy of 3D SHG for the detection of intrauterine pathology. Multicenter studies are in order to confirm these results. Wider implications of the findings These results indicate that 3D SHG is a reliable screening tool for micropolypoid endometrium, showing high concordance with hysteroscopy. Integrating 3D SHG into routine infertility workup enables the early identification of CE, providing a less invasive diagnostic algorithm compared to diagnostic hysteroscopy and enhancing patient experience. Trial registration number No

Zitieren

APA

Papa, R., Costa, M., Rodriguez-Fuentes, A., Vicario, R., Martín-Palumbo, G., Rouleau, J., Carlon, D. V., Ciocci, L., Hernandez, J., & Palumbo, A. (2026). L26/P-346 Three-dimensional sonohysterography as a screening test for chronic endometritis: a patient-friendly, minimally invasive tool in infertility practice. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.682

Vancouver

Papa R, Costa M, Rodriguez-Fuentes A, Vicario R, Martín-Palumbo G, Rouleau J, et al. L26/P-346 Three-dimensional sonohysterography as a screening test for chronic endometritis: a patient-friendly, minimally invasive tool in infertility practice. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.682

BibTeX
@article{Papa2026,
  author = {Papa, R. and Costa, M. and Rodriguez-Fuentes, A. and Vicario, R. and Martín-Palumbo, G. and Rouleau, J.P. and Carlon, D. Vasquez and Ciocci, L. and Hernandez, J. and Palumbo, A.},
  title = {L26/P-346 Three-dimensional sonohysterography as a screening test for chronic endometritis: a patient-friendly, minimally invasive tool in infertility practice},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.682}
}
Kostenlos starten →